Open Government Canada
Notice - Prescription Drug List (PDL): Mometasone furoate
Published by Health Canada | Santé Canada
About this dataset
The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to allow the nonprescription use of Mometasone furoate for the conditions listed below. Only the Human part of the PDL was revised.